Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma

Eva Gimeno, Blanca Sánchez-González, Alberto Álvarez-Larrán, Carmen Pedro, Eugenia Abella, Josep Comín, Silvia Saumell, Francesc García-Pallarols, Miquel Gómez, Carles Besses, Antonio Salar

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences